Alicja Arts։ Being a Superhero by Donating Blood
Alicja Arts, Founder of Nutrintelligence, shared a post on LinkedIn:
“I wanted to be a superhero’ine as a kid, who didn’t, right?
Then I grew up, realised Disney and Marvel were big scams,
I got a ‘real’ job and carried a regular life.
I’ve been donating blood for 20 years now (yup, I started early) across 3 different countries.
Today is my first plasma donation at Sanquin.
It will be used for immune system treatments, bleeding disorders, autoimmune diseases and to create medicine for people with muscle disease.
One day a friend asked me why do I do it?
I found it a weird question, but I answered:
‘Why wouldn’t I? It costs me nothing (other than 1h of my time) and if I can help someone, why not?’
Then I thought about it and realised blood giving truly is the easiest & most ‘efficient’ (lowest cost vs highest impact) way to literally save human lives.
Turns out I’ve been a superhero for all these years afterall.
And you could be too!
If you’re not doing it already, hopefully this post will make you consider contacting your local blood bank.”
Stay updated with Hemostasis Today.
-
May 28, 2026, 04:59Maria Sol Andres: Exploring Lipid Disorders in Modern Cancer Care
-
May 28, 2026, 04:42Francesca Granata: Representing the Porphyria Community at the 79th World Health Assembly
-
May 28, 2026, 04:29Samone Cook: When Collaboration Turns Into Organizational Coagulation
-
May 28, 2026, 03:42Lara Bloom: 15,000 Steps, Countless Conversations – One Unforgettable WHA79
-
May 27, 2026, 23:00Octavio Marques Pontes-Neto: Exchanging Latin American Experiences at the Global Stroke Alliance Meeting in Buenos Aires
-
May 27, 2026, 17:51Nita Radhakrishnan: Post Graduate Institute of Child Health Receives WFH Data Quality Certification for Excellence
-
May 27, 2026, 17:51Fiona Robinson: What exactly Are Rebalancing Agents for Bleeding Aisorders?
-
May 27, 2026, 17:14Khurram Nasir: Can Earlier LDL-C Lowering Change the Trajectory of Cardiovascular Disease?
-
May 27, 2026, 17:09Yvonne Jongejan: Allele-Selective Silencing Therapy for VWD and Thrombotic Disorders